INBX stock results show that Inhibrx Biosciences beat analyst estimates for earnings per share the second quarter of 2024. More
Articles
Pro Predictions: 3 Stocks That Could Surge Under the Proposed Tax Policies of a Trump Administration
More tariffs and less taxes will be the key features of potential Trump policies so find stocks to buy that will profit from those actions. More
SMCI Stock Outlook: Super Micro Is Crashing. Is It Worth a Contrarian Bet?
Let's dive into whether Super Micro is a stock long-term investors should buy on the dip, or simply avoid given the macro uncertainty. More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday and we have all of the biggest stories traders need to know about this morning! More
Market Meltdown or Massive Opportunity? 7 Stocks to Watch
Recent volatility in the markets has created a must watch group of stocks to understand for future movements. More
Down 24% In the Past Month, Will AMD Stock Remain In Nvidia’s Shadow?
Can AMD stock deliver gains from here as it faces significant challenges in competing with Nvidia in the AI chips market? More
3 Cruise Stocks to Buy on the Dip: August 2024
Explore why these cruise stocks present attractive investment cases as they navigate the industry's post-COVID recovery. More
